A detailed history of Bdf Gestion transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bdf Gestion holds 36,825 shares of EW stock, worth $3.18 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
36,825
Previous 44,483 17.22%
Holding current value
$3.18 Million
Previous $3.48 Billion 17.68%
% of portfolio
0.34%
Previous 0.39%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 09, 2025

SELL
$73.75 - $81.83 $564,777 - $626,654
-7,658 Reduced 17.22%
36,825 $2.86 Billion
Q2 2025

Jul 11, 2025

SELL
$67.07 - $78.22 $325,088 - $379,132
-4,847 Reduced 9.83%
44,483 $3.48 Billion
Q4 2024

Jan 23, 2025

SELL
$64.54 - $75.92 $413,443 - $486,343
-6,406 Reduced 11.49%
49,330 $3.65 Billion
Q2 2024

Jul 11, 2024

BUY
$84.3 - $94.31 $4.7 Million - $5.26 Million
55,736 New
55,736 $5.15 Billion

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $53.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Bdf Gestion Portfolio

Follow Bdf Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bdf Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Bdf Gestion with notifications on news.